OSX — Osteopore Share Price
- AU$34.08m
- AU$34.16m
- AU$2.22m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 78.79 | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | n/a | ||
Price to Sales | 15.37 | ||
EV to EBITDA | n/a |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -1111.64% | ||
Return on Equity | -392.19% | ||
Operating Margin | -217.07% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | AU$m | 0.41 | 1.5 | 1.11 | 1.69 | 2.22 | n/a | n/a | 52.35% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Osteopore Limited is an Australia-based medical technology company. The Company is engaged in commercializing a range of bespoke products specifically engineered to facilitate bone healing across multiple therapeutic areas. The Company’s patented technology fabricates specific micro-structured scaffolds for bone regeneration through three-dimensional (3D) printing and bioresorbable material. The Company’s Osteoplug in plug and strip configuration fills craniotomy gaps effortlessly. It also promotes bone tissue integration, from the skull to the bone flap. Its craniofacial products include Osteomesh, Osteoplug, and Osteoplug-C. It also offers craniotomy, orbital floor reconstruction, socket preservation, cranioplasty patient-specific implants (PSI), craniosynostosis, guided bone regeneration, minimally invasive skull base surgery, endoscopic transsphenoidal skull base surgery, burr hole restoration with the shunt drainage system, mandible PSI, immediate implant loading, and more.
Directors
- Brett Sandercock NEC (54)
- Khoon Seng Goh CEO
- Carl Runde CFO
- Lim Jing CTO
- Deborah Ho SEC
- Teoh Swee Hin NED
- Vlado Bosanac NID
- Daniel Ow NID
- Last Annual
- December 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- December 11th, 2018
- Public Since
- September 23rd, 2019
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Australian Stock Exchange - SEATS
- Shares in Issue
- 113,615,579
- Address
- Ground Floor, 16 Ord St, Perth, 6005
- Web
- https://www.osteopore.com/
- Phone
- +61 894820500
- Auditors
- Grant Thornton Audit Pty Ltd
Upcoming Events for OSX
Osteopore Ltd Annual Shareholders Meeting
Half Year 2024 Osteopore Ltd Earnings Release
Similar to OSX
4DMedical
Australian Stock Exchange - SEATS
Adherium
Australian Stock Exchange - SEATS
Allegra Medical Technologies
Australian Stock Exchange - SEATS
Ansell
Australian Stock Exchange - SEATS
Anteris Technologies
Australian Stock Exchange - SEATS
FAQ
As of Today at 19:16 UTC, shares in Osteopore are trading at AU$0.30. This share price information is delayed by 15 minutes.
Shares in Osteopore last closed at AU$0.30 and the price had moved by +33.16% over the past 365 days. In terms of relative price strength the Osteopore share price has outperformed the ASX All Ordinaries Index by +24.04% over the past year.
There is no consensus recommendation for this security.
Osteopore does not currently pay a dividend.
Osteopore does not currently pay a dividend.
Osteopore does not currently pay a dividend.
To buy shares in Osteopore you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of AU$0.30, shares in Osteopore had a market capitalisation of AU$34.08m.
Here are the trading details for Osteopore:
- Country of listing: Australia
- Exchange: ASX
- Ticker Symbol: OSX
Based on an overall assessment of its quality, value and momentum Osteopore is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Osteopore. Over the past six months, its share price has outperformed the ASX All Ordinaries Index by +63.85%.
As of the last closing price of AU$0.30, shares in Osteopore were trading +81.51% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Osteopore PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at AU$0.30.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Osteopore's management team is headed by:
- Brett Sandercock - NEC
- Khoon Seng Goh - CEO
- Carl Runde - CFO
- Lim Jing - CTO
- Deborah Ho - SEC
- Teoh Swee Hin - NED
- Vlado Bosanac - NID
- Daniel Ow - NID